BioCentury | Aug 7, 2019
Company News

Fosun’s sale of UFH reflects China’s shifting hospital landscape

...$711 million in new equity raised from a consortium of investors including Vivo Capital and Nan Fung Group...
BioCentury | Jul 19, 2019
Company News

July 19 Company Quick Takes: First biosimilars of Avastin, Herceptin launched; plus Gilenya, Celltrion-Nan Fung and Celgene

...Celltrion, Nan Fung create biosimilars JV Celltrion Inc. (KOSDAQ:068270) formed a joint venture with Nan Fung Group...
BioCentury | May 25, 2018
Financial News

Pivotal closes China fund at $150M

...Fung Life Sciences, which itself operates as a subsidiary of Hong Kong-based real estate conglomerate Nan Fung Group...
BioCentury | May 24, 2018
Financial News

Pivotal closes China fund at $150M

...Fung Life Sciences, which itself operates as a subsidiary of Hong Kong-based real estate conglomerate Nan Fung Group...
BioCentury | May 24, 2018
Finance

Chasing China

...$150 million fund, which will invest in Chinese biotechs with in-licensed portfolios. Real estate conglomerate Nan Fung Group...
...into Pivotal funds, or if there are some good buyout or PE opportunities.” Virginia Li, Assistant Editor Nan Fung Group Pivotal...
BioCentury | May 18, 2018
Finance

China comes to Europe

...of their headquarters. (A) Pivotal bioVenture, while based in the U.S., is solely funded by Nan Fung Group...
...of their headquarters. (A) Pivotal bioVenture, while based in the U.S., is solely funded by Nan Fung Group...
BioCentury | May 18, 2018
Financial News

Stapled peptide company FOG raises $66M series B

...B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group...
BioCentury | May 16, 2018
Financial News

Stapled peptide company FOG raises $66M series B

...B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group...
BioCentury | Mar 17, 2017
Finance

Practice makes Pivotal

...Fund and SV Life Sciences . She co-founded the firm with Vincent Cheung, COO of Nan Fung Group...
BioCentury | Mar 16, 2017
Financial News

Pivotal debuts with $301M life sciences fund

...at Roche Venture Fund and SV Life Sciences . Cheung is COO of Hong Kong-based Nan Fung Group...
Items per page:
1 - 10 of 10
BioCentury | Aug 7, 2019
Company News

Fosun’s sale of UFH reflects China’s shifting hospital landscape

...$711 million in new equity raised from a consortium of investors including Vivo Capital and Nan Fung Group...
BioCentury | Jul 19, 2019
Company News

July 19 Company Quick Takes: First biosimilars of Avastin, Herceptin launched; plus Gilenya, Celltrion-Nan Fung and Celgene

...Celltrion, Nan Fung create biosimilars JV Celltrion Inc. (KOSDAQ:068270) formed a joint venture with Nan Fung Group...
BioCentury | May 25, 2018
Financial News

Pivotal closes China fund at $150M

...Fung Life Sciences, which itself operates as a subsidiary of Hong Kong-based real estate conglomerate Nan Fung Group...
BioCentury | May 24, 2018
Financial News

Pivotal closes China fund at $150M

...Fung Life Sciences, which itself operates as a subsidiary of Hong Kong-based real estate conglomerate Nan Fung Group...
BioCentury | May 24, 2018
Finance

Chasing China

...$150 million fund, which will invest in Chinese biotechs with in-licensed portfolios. Real estate conglomerate Nan Fung Group...
...into Pivotal funds, or if there are some good buyout or PE opportunities.” Virginia Li, Assistant Editor Nan Fung Group Pivotal...
BioCentury | May 18, 2018
Finance

China comes to Europe

...of their headquarters. (A) Pivotal bioVenture, while based in the U.S., is solely funded by Nan Fung Group...
...of their headquarters. (A) Pivotal bioVenture, while based in the U.S., is solely funded by Nan Fung Group...
BioCentury | May 18, 2018
Financial News

Stapled peptide company FOG raises $66M series B

...B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group...
BioCentury | May 16, 2018
Financial News

Stapled peptide company FOG raises $66M series B

...B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group...
BioCentury | Mar 17, 2017
Finance

Practice makes Pivotal

...Fund and SV Life Sciences . She co-founded the firm with Vincent Cheung, COO of Nan Fung Group...
BioCentury | Mar 16, 2017
Financial News

Pivotal debuts with $301M life sciences fund

...at Roche Venture Fund and SV Life Sciences . Cheung is COO of Hong Kong-based Nan Fung Group...
Items per page:
1 - 10 of 10